Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Recruiting N/A Interventional Study
Preeclampsia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
400 (estimated)
Sponsor
Centre Hospitalier le Mans · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia. Regardless of its definition, preeclampsia is associated with an increased risk o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years * Having signed the informed consent * Person affiliated to social security Exclusion Criteria: * Patient with mental dis…
Contacts

Christelle JADEAU

+33 2 44 71 07 81

cjadeau@ch-lemans.fr

CONTACT